GlassScriptPhysician profile
Alison M Boyce
NPI 1356034490
$1,209.58
in general payments reported to CMS, 2019-2025
17 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $346 · 2024: $520 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.60 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $281.70 | 2023-2025 | Lynparza, Onglyza |
| E.R. Squibb & Sons, L.L.C. | $144.43 | 2023-2025 | Opdivo |
| Incyte Corporation | $120.73 | 2023-2024 | Jakafi |
| Celgene Corporation | $90.39 | 2023-2025 | Reblozyl, Pomalyst, Opdivo |
| Novartis Pharmaceuticals Corporation | $89.99 | 2024-2025 | |
| Pfizer INC. | $75.51 | 2023-2025 | |
| Glaxosmithkline, LLC. | $74.95 | 2023-2024 | Zejula |
| Genentech USA, INC. | $71.99 | 2024-2025 | Venclexta, Tecentriq |
| Abbvie INC. | $60.14 | 2025 | |
| Aveo Pharmaceuticals, INC. | $43.68 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.60 | 2023-2024 | |
| Eisai INC. | $23.69 | 2024 | |
| Exelixis INC. | $23.43 | 2024 | Cabometyx |
| Janssen Biotech, INC. | $22.62 | 2024 | Darzalex, Tecvayli, Talvey |
| Ipsen Biopharmaceuticals, INC | $22.50 | 2024 | Onivyde |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $21.36 | 2024 | Mektovi, Xalkori, Lorbrena |
| Amgen INC. | $15.87 | 2023 | Lumakras |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Boyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.